United Advisor Group’s AbbVie ABBV Stock Holding History

United Advisor Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.25M	Buy	5,750 +53	+0.9%	+$11.8K	0.15%	160
2025 Q4	$1.3M	Buy	5,697 +272	+5%	+$62K	0.16%	151
2025 Q3	$1.26M	Buy	5,425 +2,317	+75%	+$472K	0.17%	140
2025 Q2	$577K	Buy	3,108 +190	+7%	+$35.3K	0.1%	200
2025 Q1	$611K	Sell	2,918 -1,554	-35%	-$302K	0.13%	164
2024 Q4	$795K	Buy	4,472 +90	+2%	+$16.5K	0.16%	149
2024 Q3	$865K	Buy	4,382 +2,075	+90%	+$387K	0.2%	118
2024 Q2	$396K	Buy	+2,307	New	+$382K	0.12%	166

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

United Advisor Group's ABBV Position: Q1 2026 in Review

United Advisor Group increased its AbbVie (ABBV) stake by 0.93% in Q1 2026, buying an estimated $11.8K and bringing the position to 5,750 shares worth $1.25M. The position accounts for 0.15% of the portfolio, ranked #160.

United Advisor Group first reported a position in ABBV in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.3M in Q4 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

United Advisor Group held 5,750 shares of AbbVie worth $1.25M as of Q1 2026.
United Advisor Group bought 53 AbbVie shares in Q1 2026, an estimated $11.8K.
AbbVie made up 0.15% of United Advisor Group's portfolio in Q1 2026, its #160 holding.
United Advisor Group first reported a position in AbbVie in Q2 2024 and has held it in 8 quarters since.
United Advisor Group's AbbVie position peaked at $1.3M in Q4 2025.
4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on United Advisor Group's 13F filing for Q1 2026, filed 17 Apr 2026.